{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:04:23Z","timestamp":1785153863942,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8207130869"],"award-info":[{"award-number":["8207130869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073827"],"award-info":[{"award-number":["82073827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2019GSF108037"],"award-info":[{"award-number":["2019GSF108037"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["2019LJ003"],"award-info":[{"award-number":["2019LJ003"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["2019QL011"],"award-info":[{"award-number":["2019QL011"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellsig.2026.112654","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:32:03Z","timestamp":1780759923000},"page":"112654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases"],"prefix":"10.1016","volume":"146","author":[{"given":"Xuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-zhuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-xuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112654_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110689","article-title":"Phosphodiesterase 7 as a therapeutic target - where are we now?","volume":"108","author":"Zorn","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2026.112654_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2026.112654_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(03)00122-3","article-title":"Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory","volume":"112","author":"Lee","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112654_bb0020","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s13555-023-01054-3","article-title":"Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: a narrative review","volume":"13","author":"Blauvelt","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.cellsig.2026.112654_bb0025","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"15","key":"10.1016\/j.cellsig.2026.112654_bb0030","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1073\/pnas.95.15.8991","article-title":"Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase","volume":"95","author":"Soderling","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112654_bb0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cellsig.2026.112654_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cellsig.2017.11.004","article-title":"Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain","volume":"42","author":"Kelly","year":"2018","journal-title":"Cell. Signal."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112654_bb0045","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1021\/acs.jmedchem.0c01573","article-title":"Rational design of 2-Chloroadenine derivatives as highly selective phosphodiesterase 8A inhibitors","volume":"63","author":"Huang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2008-0091TR","article-title":"Cyclic AMP: master regulator of innate immune cell function","volume":"39","author":"Serezani","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yjmcc.2010.03.016","article-title":"Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes","volume":"49","author":"Patrucco","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2016.00259","article-title":"Differential expression and function of PDE8 and PDE4 in effector T cells: implications for PDE8 as a drug target in inflammation","volume":"7","author":"Vang","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112654_bb0065","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.101131098","article-title":"T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3","volume":"98","author":"Glavas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012011","article-title":"PDE8 regulates rapid teff cell adhesion and proliferation independent of ICER","volume":"5","author":"Vang","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112654_bb0075","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.40040","article-title":"Genome-wide association analysis reveals genetic heterogeneity of Sjogren\u2019s syndrome according to ancestry","volume":"69","author":"Taylor","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-015-3445-9","article-title":"Inhibition of breast cancer cell migration by activation of cAMP signaling","volume":"152","author":"Dong","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2006.04.143","article-title":"Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes","volume":"345","author":"Dong","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071279","article-title":"A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition","volume":"8","author":"Demirbas","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.124.324475","article-title":"AKAP12 overexpression affects cardiac function via PDE8","volume":"134","author":"Subramanian","year":"2024","journal-title":"Circ. Res."},{"issue":"27","key":"10.1016\/j.cellsig.2026.112654_bb0100","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/eurheartj\/ehad086","article-title":"Phosphodiesterase 8 governs cAMP\/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism","volume":"44","author":"Pavlidou","year":"2023","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0105","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s11064-024-04156-2","article-title":"Phosphodiesterase 8 (PDE8): distribution and cellular expression and association with Alzheimer\u2019s disease","volume":"49","author":"Qiu","year":"2024","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112654_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf028","article-title":"Cognitive improvement effects of PF-04957325, a phosphodiesterase-8 inhibitor, in mouse models of Alzheimer\u2019s disease via modulating neuroinflammation","volume":"28","author":"Guo","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112654_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040660","article-title":"Treatment of experimental autoimmune encephalomyelitis with an inhibitor of Phosphodiesterase-8 (PDE8)","volume":"11","author":"Basole","year":"2022","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2026.112654_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1119(01)00783-1","article-title":"Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution","volume":"280","author":"Wang","year":"2001","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112654_bb0125","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0006-291X(02)02371-9","article-title":"Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene","volume":"297","author":"Hayashi","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2026.112654_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(03)00809-6","article-title":"Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain","volume":"319","author":"Kobayashi","year":"2003","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112654_bb0135","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ejhg.2008.85","article-title":"A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex","volume":"16","author":"Horvath","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0014-4886(03)00042-6","article-title":"Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer\u2019s disease brains examined by in situ hybridization","volume":"182","author":"Perez-Torres","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0145","doi-asserted-by":"crossref","first-page":"1427200","DOI":"10.3389\/fimmu.2024.1427200","article-title":"Single-cell transcriptomic analysis identifies downregulated phosphodiesterase 8B as a novel oncogene in IDH-mutant glioma","volume":"15","author":"He","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112654_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchemneu.2011.07.002","article-title":"Distribution of PDE8A in the nervous system of the Sprague-Dawley rat","volume":"42","author":"Kruse","year":"2011","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","article-title":"Select 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain","volume":"26","author":"Kelly","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2026.112654_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117009","article-title":"Beyond PDE4 inhibition: a comprehensive review on downstream cAMP signaling in the central nervous system","volume":"177","author":"Donders","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112654_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2012.05.050","article-title":"Synaptic changes in Alzheimer's disease and its models","volume":"251","author":"Pozueta","year":"2013","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112654_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1570159X17666181127125704","article-title":"Current drugs and potential future neuroprotective compounds for Parkinson\u2019s disease","volume":"17","author":"Carrera","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1601-183X.2012.00836.x","article-title":"Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay","volume":"11","author":"Tsai","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.cellsig.2026.112654_bb0180","first-page":"L418","article-title":"Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia","volume":"281","author":"Shenkar","year":"2001","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.cellsig.2026.112654_bb0185","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1046\/j.1432-1033.2002.03157.x","article-title":"Inhibition of the NF-kappaB transcriptional activity by protein kinase a","volume":"269","author":"Takahashi","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112654_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112990","article-title":"Microglia and Alzheimer\u2019s disease","volume":"23","author":"Merighi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"beta-amyloid peptides and amyloid plaques in Alzheimer\u2019s disease","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","article-title":"Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer\u2019s brain","volume":"115","author":"Wang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellsig.2026.112654_bb0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.molmed.2005.08.004","article-title":"Proteolytic mechanisms in amyloid-\u03b2 metabolism: therapeutic implications for Alzheimer\u2019s disease","volume":"11","author":"Vardy","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cellsig.2026.112654_bb0210","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2353\/ajpath.2008.070620","article-title":"Neprilysin: an enzyme candidate to slow the progression of Alzheimer\u2019s disease","volume":"172","author":"El-Amouri","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720508783954703","article-title":"Neprilysin and amyloid beta peptide degradation","volume":"5","author":"Hersh","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cellsig.2026.112654_bb0220","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0225","doi-asserted-by":"crossref","first-page":"24575","DOI":"10.1016\/S0021-9258(17)31430-8","article-title":"A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase","volume":"269","author":"Duckworth","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2026.112654_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer\u2019s disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cellsig.2026.112654_bb0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neulet.2008.04.025","article-title":"Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer\u2019s disease-like neuropathology","volume":"438","author":"Vepsalainen","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cellsig.2026.112654_bb0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/002215549904700403","article-title":"Cellular distribution of endothelin-converting enzyme-1 in human tissues","volume":"47","author":"Korth","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.cellsig.2026.112654_bb0245","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s43587-025-00879-1","article-title":"Boosting angiotensin-converting enzyme (ACE) in microglia protects against Alzheimer\u2019s disease in 5xFAD mice","volume":"5","author":"Gomez","year":"2025","journal-title":"Nat. Aging"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112654_bb0250","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2011.04.068","article-title":"Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid \u03b2-induced cognitive deficits associated with decreased amyloid \u03b2 accumulation","volume":"408","author":"Park","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112654_bb0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11064-025-04516-6","article-title":"Ameliorative role of Phosphodiesterase-5 (PDE-5) inhibitor \u201cavanafil\u201d via modulating cAMP & cGMP pathway against Alzheimer\u2019s disease","volume":"50","author":"Talib","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cellsig.2026.112654_bb0260","article-title":"Dual PDE4\/10A inhibition restores CREB1 function and enhances neuronal resilience in models of alzheimer\u2019s disease","volume":"17(1):231","author":"Rong","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.cellsig.2026.112654_bb0265","doi-asserted-by":"crossref","first-page":"177830","DOI":"10.1016\/j.ejphar.2025.177830","article-title":"LRP1 at the crossroads of Parkinson\u2019s and Alzheimer\u2019s: divergent roles in alpha-synuclein and amyloid pathology","volume":"1002","author":"Alshahrani","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7905486","article-title":"P-glycoprotein (ABCB1) and oxidative stress: focus on Alzheimer\u2019s disease","volume":"2017","author":"Sita","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.cellsig.2026.112654_bb0275","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2026.112654_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.intimp.2012.03.021","article-title":"Effects of triptolide on the synaptophysin expression of hippocampal neurons in the AD cellular model","volume":"13","author":"Nie","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13108","article-title":"TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer\u2019s neuropathology","volume":"33","author":"Fracassi","year":"2023","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"BDNF and synaptic plasticity, cognitive function, and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0295","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s42003-024-05860-z","article-title":"Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer's mouse model and stimulates synaptic plasticity pathway enzymes","volume":"7","author":"Di Lucente","year":"2024","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn997","article-title":"PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity","volume":"6","author":"Esteban","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112654_bb0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neuropharm.2005.04.018","article-title":"Plasticity-specific phosphorylation of CaMKII, MAP-kinases and CREB during late-LTP in rat hippocampal slices in vitro","volume":"49","author":"Ahmed","year":"2005","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112654_bb0310","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41422-025-01174-9","article-title":"Autism-related proteins form a complex to maintain the striatal asymmetry in mice","volume":"35","author":"Jiang","year":"2025","journal-title":"Cell Res."},{"issue":"10004","key":"10.1016\/j.cellsig.2026.112654_bb0315","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O'Brien","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112654_bb0320","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuint.2019.01.005","article-title":"Inhibition of miR-497 improves functional outcome after ischemic stroke by enhancing neuronal autophagy in young and aged rats","volume":"127","author":"Chen","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cellsig.2026.112654_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101734","article-title":"Vascular dementia: A microglia\u2019s perspective","volume":"81","author":"Yang","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0335","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.apsb.2022.02.012","article-title":"Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070703","article-title":"Neuroinflammation in ischemic stroke: inhibition of cAMP-specific Phosphodiesterases (PDEs) to the rescue","volume":"9","author":"Ponsaerts","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cellsig.2026.112654_bb0345","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellsig.2017.08.007","article-title":"PDE8 controls CD4(+) T cell motility through the PDE8A-Raf-1 kinase signaling complex","volume":"40","author":"Basole","year":"2017","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0350","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-011-0840-0","article-title":"The neuropathological basis of clinical progression in multiple sclerosis","volume":"122","author":"Reynolds","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0355","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.4049\/jimmunol.178.7.4632","article-title":"TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26","volume":"178","author":"Preller","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112654_bb0360","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/BJ20130064","article-title":"Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM\/ICER: a potential role for Epac","volume":"456","author":"Vang","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2026.112654_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cellsig.2026.112654_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for multiple sclerosis","volume":"7","author":"Medina-Rodriguez","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajhg.2009.12.003","article-title":"Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene","volume":"86","author":"Appenzeller","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0380","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/mdc3.14129","article-title":"A novel PDE8B gene variant associated with autosomal dominant striatal degeneration","volume":"11","author":"Chunga","year":"2024","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.cellsig.2026.112654_bb0385","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.parkreldis.2019.11.002","article-title":"Clinical findings of autosomal-dominant striatal degeneration and PDE8B mutation screening in parkinsonism and related disorders","volume":"69","author":"Ni","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112654_bb0390","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/mds.26345","article-title":"A novel mutation of PDE8B gene in a Japanese family with autosomal-dominant striatal degeneration","volume":"30","author":"Azuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cellsig.2026.112654_bb0395","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112654_bb0405","doi-asserted-by":"crossref","unstructured":"M. Safavi, M. Baeeri, M. Abdollahi, New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders, Expert Opin. Drug Discovery 8(6) (2013) 733\u2013751.","DOI":"10.1517\/17460441.2013.787986"},{"key":"10.1016\/j.cellsig.2026.112654_bb0410","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1087057110362100","article-title":"New classes of PDE7 inhibitors identified by a fission yeast-based HTS","volume":"15","author":"Alaamery","year":"2010","journal-title":"J. Biomol. Screen."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0415","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ejmech.2007.10.027","article-title":"CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example","volume":"43","author":"Castro","year":"2008","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112654_bb0420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112654_bb0425","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/cmdc.200900043","article-title":"Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors","volume":"4","author":"Castano","year":"2009","journal-title":"ChemMedChem"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112654_bb0430","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.bmc.2013.01.067","article-title":"Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors","volume":"21","author":"Sanchez","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0435","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmcl.2009.02.060","article-title":"Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation","volume":"19","author":"Guo","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112654_bb0440","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0008-8749(86)90199-1","article-title":"Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3\u2032,5\u2032-cyclic adenosine monophosphate accumulation","volume":"101","author":"DosReis","year":"1986","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112654_bb0445","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrd1752","article-title":"Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab","volume":"4","author":"Steinman","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112654_bb0450","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.bmcl.2011.03.022","article-title":"1,5-substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability","volume":"21","author":"DeNinno","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112654_bb0455","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1016\/j.bmcl.2012.06.079","article-title":"Discovery of triazolopyrimidine-based PDE8B inhibitors: exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes","volume":"22","author":"DeNinno","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112654_bb0460","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1210\/en.2007-0968","article-title":"Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose","volume":"149","author":"Dov","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112654_bb0465","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/pr.117.014035","article-title":"The hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to pharmacology of a unique family of ion channels","volume":"69","author":"Sartiani","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112654_bb0470","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867324666170116125159","article-title":"PDE7-selective and dual inhibitors: advances in chemical and biological research","volume":"24","author":"Jankowska","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"6560","key":"10.1016\/j.cellsig.2026.112654_bb0475","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/379081a0","article-title":"Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB","volume":"379","author":"Barton","year":"1996","journal-title":"Nature"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:29:12Z","timestamp":1785151752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":95,"alternative-id":["S0898656826003098"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112654","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112654"}}